COVID-19 infections fell significantly—by 65% percent—after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study. Data from the COVID-19 Infection Survey, a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC), is the first to show the